Table 1.
Distribution of FIGO stage, histologic subtype, and grade in 58 patients with endometrial cancer (endometrioid, UPSC, and MMMT)
| FIGO stage | Grade 1 | Grade 2 | Grade 3 | Total |
|---|---|---|---|---|
| I | 17 (53%) | 10 (31%) | 5 (16%) | 32 |
| II | 3 (50%) | 1 (17%) | 2 (33%) | 6 |
| III | 1 (14%) | 1 (14%) | 5 (72%) | 7 |
| IV | 0 (0%) | 2 (15%) | 11 (85%) | 13 |
| Total | 21 | 14 | 23 | 58 |
| Endometrioid total | 21 | 11 | 8 | 40 |
Summary of the clinical data for the 58 patients with a diagnosis of endometrial cancer (endometrioid, n = 40; UPSC, n = 12; MMMT, n = 6). The correlation of grade with stage was statistically significant (ungrouped Spearman correlation = 0.588, P < 0.001). The data extracted included histologic type of endometrial cancer and FIGO stage. Specimens from patients with a diagnosis of endometrioid adenocarcinoma were graded: well differentiated (grade 1), moderately differentiated (grade 2), or poorly differentiated (grade 3).